Mirae Asset Global Investments’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
RBI
AA
PFSRSONJ
CUAMC
GI
SCM
FFA
Mirae Asset Global Investments's NGNE Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Neurogene (NGNE) stake by 13% in Q2 2026, selling an estimated $2.78K and leaving 707 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.
Mirae Asset Global Investments first reported a position in NGNE in Q4 2024 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.
- Mirae Asset Global Investments held 707 shares of Neurogene worth $22.2K as of Q2 2026.
- Mirae Asset Global Investments sold 101 Neurogene shares in Q2 2026, an estimated $2.78K.
- Neurogene made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1476 holding.
- Mirae Asset Global Investments first reported a position in Neurogene in Q4 2024 and has held it in 7 quarters since.
- 17 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.